For example, consistent with human data, obesity leads to increased tumor burden and faster disease progression in oncogenic Kras-driven pancreatic ductal adenocarcinoma (PDAC), but not in lung cancer [7]. Here, KRAS is linked to obesity due to melanocortin 4 receptor deficiency.